View Press Releases
-
Dyadic C1 protein expression platform explored in fight against COVID-19
JUPITER, FL, UNITED STATES - Oct 30, 2020 - Dyadic International, Inc. (NASDAQ: DYAI) a leading biotechnology innovator focused on accelerating the development and lowering the manufacturing costs of vaccines and biopharmaceuticals, recently announced results which further support record expression levels of the SARS-CoV-2 Receptor Binding Domain (RBD) antigen produced from Dyadics industrially proven proprietary & patented hyper-productive C1 gene expression platform
Oct 30, 2020
-
Muscular Dystrophy Association Launches MOVR Visualization and Reporting Platform to Improve Patient Care and Accelerate Drug Discovery
NEW YORK, NY, UNITED STATES - Oct 29, 2020 - The Muscular Dystrophy Association (MDA) announced today the launch of the neuroMuscular ObserVational Research (MOVR) Visualization and Reporting Platform (VRP)
Oct 29, 2020
-
Plus Therapeutics Announces Initiation of Final Cohort of ReSPECT™ Glioblastoma Trial
AUSTIN, TX - Oct 29, 2020 - Plus Therapeutics, Inc. (Nasdaq: PSTV) (the Company), today announced that it has treated the first patient in the sixth and final cohort of its National Cancer Institute (NCI)-supported, multi-center ReSPECT Phase 1 dose-finding clinical trial evaluating Rhenium NanoLiposomes (RNL) for the treatment of recurrent glioblastoma (GBM)
Oct 29, 2020
-
7th Crystal Structure Prediction Blind Test brings new challenges for computational chemists
CAMBRIDGE, UNITED KINGDOM - Oct 28, 2020 - Announcing the new challengeThis week the 7th CSP Blind Test begins - a major challenge in computational chemistry
Oct 28, 2020
-
OmniTier Streamlines Personalized Medicine Workflows with CompStor Insight™ for Next-Generation Sequencing Tertiary Analysis
MILPITAS, CA, UNITED STATES - Oct 27, 2020 - OmniTier Inc., an AI and multiomics application company whose bioinformatics solutions help deliver the promise of personalized medicine, debuted the CompStor Insight appliance for tertiary analysis in next-generation sequencing (NGS) applications
Oct 27, 2020
-
Vidence And 2bPrecise Announce Strategic Partnership To Unleash The Power Of Genomic Data In Precision Oncology
RALEIGH, NC, UNITED STATES - Oct 27, 2020 - Vidence, an oncology informatics company, has selected the 2bPrecise platform, a precision medicine data delivery solution, to make it easier for its Consortium Fellows to unlock the true power of genomic data at the point of care and facilitate the advancement of precision oncology
Oct 27, 2020
-
Baptist Health Engages Kyruus to Enable Next-Generation Online Patient Access Experience
BOSTON, MA, UNITED STATES - Oct 27, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that Baptist Health, the largest not-for-profit health system in Kentucky, has engaged the company to help elevate its digital access experience for consumers
Oct 27, 2020
-
Alfa Chemistry Offers Fluorinated Building Blocks for Material, Medicinal, Agricultural, Organic Chemistry Research
NY, NY - Oct 14, 2020 - The benefits of fluorochemistry to pharmaceutical applications are obvious and the past decades has seen increasing synthesis of fluorinated compounds in the preparation of new pharmaceuticals and agrochemicals
Oct 26, 2020
-
AI & Medicine Announces Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling for Drug Discovery
NY, NY, UNITED STATES - Oct 21, 2020 - AI & Medicine, one of the forerunners in the AI-assisted medicine area, announces it now provides PK/PD modeling service to help scientists and researchers more efficiently screen drugs and thus accelerating the process of new drug development
Oct 26, 2020
-
Protheragen Offers License Opportunities for Drug Development Programs
RONKONKOMA, NY - Oct 27, 2020 - Aiming to build a bridge between academics and industry, Protheragen, a company founded in Ronkonkoma, New York, 2009, announces to offer license opportunities for drug R&D companies
Oct 26, 2020
-
Scientific Knowledge Discovery Platform Pioneer, Eagle Genomics, Closes $9M in Scale-Up Funding as Major Brands Home in on the Microbiome Megatrend
CAMBRIDGE, UNITED KINGDOM - Oct 26, 2020 - Eagle Genomics, a pioneer in applying network science to biology – particularly linked to the microbiome – has closed $9 million in new scale-up funding
Oct 26, 2020
-
Shimmer Solicits Clinical Research Community Input on Expanded Open Wearables Initiative (OWEAR) Vision
CAMBRIDGE, MA - Oct 26, 2020 - Shimmer Research, a global leader in wearable technology for research applications, today announced that the Open Wearables Initiative (OWEAR) is evaluating a significant expansion of its vision and seeking industry input to build consensus
Oct 26, 2020
-
NCH Healthcare System Partners with eVideon to Enhance Digital Patient Engagement and Education
NEWTON, MI, UNITED STATES - Oct 26, 2020 - eVideon, a leader in interactive patient engagement and digital workflow solutions, today announced that NCH Healthcare System, one of the largest healthcare systems in Southwest Florida, will be implementing the companys full suite of solutions in 576 patient rooms across its two hospitals
Oct 26, 2020
-
AVIA Names Linda Finkel as CEO
CHICAGO, IL, UNITED STATES - Oct 23, 2020 - AVIA, the nations leading digital transformation partner for healthcare organizations, announced that its board of directors has appointed AVIA President Linda Finkel to also serve as chief executive officer, effective November 1, 2020
Oct 23, 2020
-
BOC Sciences Lanuched A New Biotinylation Platform
SHIRLEY, NY, UNITED STATES - Oct 23, 2020 - Recently, BOC Sciences, a New York-based chemical and pharmaceutical supplier, announced to launch a new biotinylation technology platform for the scientific community
Oct 22, 2020
-
Profacgen Updated Its Pull Down Assay Service for Protein Interaction Study
SHIRLEY, NY, UNITED STATES - Oct 22, 2020 - Profacgen, with an organized team of scientists with extensive experience in the study of protein-protein interaction, recently updated its pull down assay service to help efficiently and specifically verify the predicted protein-protein interactions or identify novel interactions
Oct 22, 2020
-
Elsevier Signs Collaboration to Develop Novel Prediction Tool to Reduce Drug Development Safety Risk
LONDON, UNITED KINGDOM - Oct 22, 2020 - Elsevier, a global information analytics business specializing in science and health, today announced its collaboration with the pharmaceutical company Novartis to develop a safety margin risk assessment prediction tool, largely using PharmaPendium data
Oct 22, 2020
-
Aurinia Pharmaceuticals selects MyMeds&Me’s Reportum QuickStart platform to streamline drug safety reporting
LONDON, UK - Oct 21, 2020 - MyMeds&Me, a leading provider of drug safety software to transform the end-to-end pharmacovigilance process, have today announced that Aurinia Pharmaceuticals Inc
Oct 21, 2020
-
Alfa Chemistry Testing Lab Builds an Exclusive Regulatory Resource Section on Its Website
NY, NY - Oct 21, 2020 - For customers who are not familiar with industry regulations, Alfa Chemistry Testing Lab has recently built an exclusive section of regulatory resource section for them on its website for reference purposes
Oct 20, 2020
-
MDI Biological Laboratory Awarded $3.14 Million for Kidney Research
BAR HARBOR, ME, UNITED STATES - Oct 20, 2020 - The MDI Biological Laboratory has announced that it has received a grant of $3.14 million over five years from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute of the National Institutes of Health (NIH), for the development of artificial kidney tissue to replace human kidney tissue that is lost to disease or injury
Oct 20, 2020